Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
基本信息
- 批准号:10683866
- 负责人:
- 金额:$ 19.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-24 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
RCMI Administrative Core Summary
The RCMI Cancer Research Center at Xavier University will provide a critical platform for researchers of
diverse training and expertise to effectively address racial disparities with a focus on cancer biology, cancer
prevention, diagnosis, treatment and clinical outcome. The overarching goal of the RCMI Program at Xavier
University is to enhance biomedical research capacity in minority health and health disparities. To reach this
goal, we plan to enhance faculty and programmatic research competitiveness, especially in the areas of
cancer, minority health disparities and translational research. The Administrative Core will function as the
managing unit of Xavier's RCMI program by providing leadership and creating a collaborative infrastructure
that manages, coordinates, integrates, and supports the scope of the RCMI program activities. The
Administrative Core will promote and facilitate integrated communications within and across the Investigator
Development, Resource Infrastructure and Community Engagement Cores and the three proposed research
projects. The Administrative Core will also be responsible for evaluating the progress of each research project
and all cores to ensure each evaluation metrics of the RCMI program are met. The Administrative Core will
effectively manage the RCMI Program by achieving five specific aims. Aim 1. Provide effective leadership in
managing the key RCMI activities. The Admin Core leadership team will consist of PIs, Core Directors, and
Program Managers, have monthly meetings to review progress, identify problems, discuss and implement
solutions and improvement plans to ensure that each program goal is achieved as measured by assessment
milestones. Aim 2. To implement processes for efficient use of the research infrastructure core facilities. The
Administrative Core will have monthly standing meetings with the core faculty expertise group to review core
operations, policies and procedures. Quarterly core service surveys and quarterly core service reports will be
collected which track user satisfaction, core efficiency, and outcomes as measured by core-citing publications
and grant applications with core participation. Aim 3. To provide administrative assistance in developing
successful grant proposals for external support. The Admin Core will work collaboratively with Xavier's Office
of Research and Sponsored Programs (ORSP) to assist faculty and staff in obtaining external grants and
contracts, including identifying potential sources of funding, providing professional review of proposals prior to
submission, and assisting faculty in the administration of their grants. The RCMI will organize seminars and
grant writing workshops jointly with ORSP and provide financial and logistic support to a network of mentors for
pilot projects and junior investigators in developing grantsmanship. Aim 4. To promote and facilitate the
development of a diverse pool of investigators actively engaged in research on minority health and health
disparity diseases, and in community-based behavioral research. The Investigator Development Core will
support early stage investigators in conducting basic biomedical research related to cancer and health
disparities as well as community-based health disparity research but who have not received independent
funding from external sources such as NIH. Aim 5. To implement the RCMI Program evaluation plan by
coordinating with the RCMI Advisory Committee, the CEC Community Advisory Board, and the Independent
Evaluator. The Administrative Core will coordinate and oversee the comprehensive evaluation of the RCMI
program in enhancing the institutional infrastructure and environment necessary to facilitate biomedical
research in cancer and cancer related health disparities, increasing productivity of investigators in peer-
reviewed publications and discovery, and increasing the Xavier investigators' overall success in securing
extramural research funding. In addition, the Administrative Core will organize RCMI-wide meetings and
conferences, including meetings of the Advisory Committee and pilot project review sessions. The Admin Core
will also be responsible for ensuring compliance of all RCMI research activities with IRB and IACUC and other
federal, state, and local regulations.
RCMI管理核心摘要
Xavier大学的RCMI癌症研究中心将为研究人员提供一个关键的平台
多样化的培训和专业知识可有效解决种族差异,重点是癌症生物学,癌症
预防,诊断,治疗和临床结果。 Xavier RCMI计划的总体目标
大学旨在提高少数民族健康和健康差异的生物医学研究能力。达到这个
目标,我们计划增强教师和程序化研究的竞争力,尤其是在
癌症,少数民族健康差异和转化研究。管理核心将作为
通过提供领导和创建协作基础架构来管理Xavier的RCMI计划的单位
管理,协调,整合和支持RCMI计划活动的范围。这
行政核心将促进和促进调查员内外的集成通信
发展,资源基础设施和社区参与核心以及三项提议的研究
项目。行政核心还将负责评估每个研究项目的进度
所有核心以确保满足RCMI计划的每个评估指标。行政核心将
通过实现五个具体目标来有效地管理RCMI计划。目标1。提供有效的领导
管理关键RCMI活动。管理员核心领导团队将由PI,核心董事和
计划经理,举行每月会议来审查进度,找出问题,讨论和实施
解决方案和改进计划,以确保按评估来衡量每个计划目标
里程碑。目的2。实施流程以有效利用研究基础设施核心设施。这
行政核心将每月与核心教师专业知识小组举行会议,以审查核心
运营,政策和程序。季度核心服务调查和季度核心服务报告将是
收集了哪些跟踪用户满意度,核心效率和结果,如核心出版物所测量
并授予核心参与的申请。目标3。在开发方面提供行政帮助
成功的赠款提案以提供外部支持。管理员核心将与Xavier的办公室合作
研究和赞助计划(ORSP),以协助教职员工获得外部补助
合同,包括确定潜在的资金来源,对提案进行专业审查
提交,并协助教职员工的赠款。 RCMI将组织研讨会和
与ORSP共同授予写作研讨会,并为导师网络提供财务和后勤支持
试点项目和初级调查人员正在发展助学士技巧。目标4。促进和促进
开发各种各样的调查员,积极参与少数民族健康和健康的研究
差异疾病和基于社区的行为研究。研究者开发核心将
支持早期研究人员进行与癌症和健康有关的基本生物医学研究
差异以及基于社区的健康差异研究,但尚未获得独立
来自NIH等外部来源的资金。目标5。通过
与RCMI咨询委员会,CEC社区顾问委员会和独立
评估员。行政核心将协调和监督RCMI的全面评估
增强促进生物医学所必需的机构基础设施和环境的计划
研究癌症和癌症与健康差异的研究,提高了研究人员在同伴中的生产率
审查了出版物和发现,并增加了Xavier调查人员在确保保护方面的整体成功
校外研究资金。此外,行政核心将组织RCMI范围内的会议和
会议,包括咨询委员会的会议和试点项目审查会议。管理员核心
还将负责确保与IRB和IACUC以及其他RCMI研究活动合规
联邦,州和地方法规。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guangdi Wang其他文献
Guangdi Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guangdi Wang', 18)}}的其他基金
IND-Enabling Studies of ZB716, an Orally Bioavailable SERD
ZB716(一种口服生物可利用的 SERD)的 IND 启用研究
- 批准号:
9341848 - 财政年份:2017
- 资助金额:
$ 19.89万 - 项目类别:
Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
- 批准号:
10457022 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
- 批准号:
10303187 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
- 批准号:
10205633 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
Developing an Orally Bioavailable SERD for Treatment of Metastatic/Advanced Breast Cancer
开发口服生物可利用的 SERD 来治疗转移性/晚期乳腺癌
- 批准号:
10078882 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
- 批准号:
10322696 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
- 批准号:
10078873 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
Xavier RCMI Renewal Application-Administrative Core
Xavier RCMI 更新申请-管理核心
- 批准号:
10544040 - 财政年份:2009
- 资助金额:
$ 19.89万 - 项目类别:
相似海外基金
Genetic and Environmental risk of NAFLD-related HCC In All Latinos: the GENIAL Study
所有拉丁美洲人 NAFLD 相关 HCC 的遗传和环境风险:GENIAL 研究
- 批准号:
10856113 - 财政年份:2023
- 资助金额:
$ 19.89万 - 项目类别:
Blind/Disability and Intersectional Biases in E-Health Records (EHRs) of Diabetes Patients: Building a Dialogue on Equity of AI/ML Models in Clinical Care
糖尿病患者电子健康记录 (EHR) 中的盲/残疾和交叉偏差:建立关于临床护理中 AI/ML 模型公平性的对话
- 批准号:
10599633 - 财政年份:2021
- 资助金额:
$ 19.89万 - 项目类别:
eMERGE Phase IV Clinical Center at Mass General Brigham
麻省总医院布里格姆分校 eMERGE IV 期临床中心
- 批准号:
10625354 - 财政年份:2015
- 资助金额:
$ 19.89万 - 项目类别: